[1] GONZALES W V, MOBASHSHER A T, ABBOSH A. The progress of glucose monitoring—a review of invasive to minimally and non-invasive techniques, devices and sensors[J]. Sensors, 2019, 19(4): 800. doi: 10.3390/s19040800
[2] PEER N, BALAKRISHNA Y, DURAO S. Screening for type 2 diabetes mellitus[J]. Cochrane Database of Systematic Reviews, 2020, 5(5): CD005266.
[3] DUAN D, KENGNE A P, ECHOUFFO-TCHEUGUI J B. Screening for diabetes and prediabetes[J]. Endocrinology and Metabolism Clinics of North America, 2021, 50(3): 369-385. doi: 10.1016/j.ecl.2021.05.002
[4] ZHANG Y L, SUN J P, PANG Z C, et al. Evaluation of two screening methods for undiagnosed diabetes in China: An cost-effectiveness study[J]. Primary Care Diabetes, 2013, 7(4): 275-282. doi: 10.1016/j.pcd.2013.08.003
[5] MOHAN V, GOLDHABER-FIEBERT J D, RADHA V, et al. Screening with OGTT alone or in combination with the Indian diabetes risk score or genotyping of TCF7L2 to detect undiagnosed type 2 diabetes in Asian Indians[J]. Indian Journal of Medical Research, 2011, 133(3): 294-299.
[6] AGBOZO F, ABUBAKARI A, NARH C, et al. Accuracy of glycosuria, random blood glucose and risk factors as selective screening tools for gestational diabetes mellitus in comparison with universal diagnosing[J]. BMJ Open Diabetes Research & Care, 2018, 6(1): e000493.
[7] MARLEY J V, OH M S, HADGRAFT N T, et al. Using glycated haemoglobin testing to simplify diabetes screening in remote aboriginal Australian health care settings[J]. Medical Journal of Australia, 2015, 203(1): 28-32. doi: 10.5694/mja14.01575
[8] AHSAN H, AHMED M U D, KHAN T. Screening of young adults using HbA1c for evaluating pre-diabetic status[J]. Medical Forum Monthly, 2021, 32(7): 53-57.
[9] 吴文军, 徐蕾, 黄丽梅, 等. 2016—2017年上海市社区糖尿病高危人群筛查结果分析[J]. 中华疾病控制杂志, 2019, 23(7): 802-806.WU W J, XU L, HUANG L M, et al. Analysis of diabetes screening in high-risk population in different communities in Shanghai from 2016 to 2017[J]. Chinese Journal of Disease Control & Prevention, 2019, 23(7): 802-806(in Chinese).
[10] EDIGER M N, OLSON B P, MAYNARD J D. Noninvasive optical screening for diabetes[J]. Journal of Diabetes Science and Technology, 2009, 3(4): 776-780. doi: 10.1177/193229680900300426
[11] PAOLILLO F R, MATTOS V S, BORGHI-SILVA A, et al. Advanced glycation endproducts as biomarkers for risk of diabetes and cardiovascular diseases by skin autofluorescence: A noninvasive optical screening[J]. Photobiomodulation, Photomedicine, and Laser Surgery, 2019, 37(3): 168-174. doi: 10.1089/photob.2018.4563
[12] SEMENOVA N S, LARICHEV A V, AKOPYAN V S. Swept source optical coherence tomography: A technology review[J]. Vestnik Oftalmologii, 2020, 136(1): 111-116. doi: 10.17116/oftalma2020136011111
[13] BOUMA B E, de BOER J F, HUANG D, et al. Optical coherence tomography[J]. Nature Reviews Methods Primers, 2022, 2(1): 80. doi: 10.1038/s43586-022-00173-z
[14] MIURA T, SEIYAMA A, CASSIM M, et al. Improved accuracy of tissue glucose measurement using low magnification optical coherence tomography[J]. IEEE Sensors Letters, 2021, 5(12): 1-4.
[15] PODDAR R, SHARMA S R, ANDREWS J T, et al. Correlation between glucose concentration and reduced scattering coefficients in turbid media using optical coherence tomography[J]. Current Science, 2008, 95(3): 340-344.
[16] ESENALIEV R O, LARIN K V, LARINA I V, et al. Noninvasive monitoring of glucose concentration with optical coherence tomography[J]. Optics Letters, 2001, 26(13): 992-994. doi: 10.1364/OL.26.000992
[17] LAN Y T, KUANG Y P, ZHOU L P, et al. Noninvasive monitoring of blood glucose concentration in diabetic patients with optical coherence tomography[J]. Laser Physics Letters, 2017, 14(3): 035603. doi: 10.1088/1612-202X/aa58c0
[18] LARIN K V, ELEDRISI M S, MOTAMEDI M, et al. Noninvasive blood glucose monitoring with optical coherence tomography: A pilot study in human subjects[J]. Diabetes Care, 2002, 25(12): 2263-2267. doi: 10.2337/diacare.25.12.2263
[19] LARIN K V, MOTAMEDI M, ASHITKOV T V, et al. Specificity of noninvasive blood glucose sensing using optical coherence tomography technique: A pilot study[J]. Physics in Medicine and Biology, 2003, 48(10): 1371-1390. doi: 10.1088/0031-9155/48/10/310
[20] 周聪聪, 姚晓天, 苏亚, 等. 基于OCT无创血糖检测的图像校正补偿方法[J]. 中国激光, 2022, 49(24): 2407201.ZHOU C C, YAO X T, SU Y, et al. Image correctionand compensation method based on OCT noninvasive blood glucose detection[J]. Chinese Journal of Lasers, 2022, 49(24): 2407201 (in Chinese).
[21] 苏亚, 孟卓, 王龙志, 等. 光学相干层析无创血糖检测中相关性分析及标定[J]. 中国激光, 2014, 41(7): 0704002.SU Y, MENG Zh, WANG L Zh, et al. Correlation analysis and calibration of noninvasive blood glucose monitoring in vivo with optical coherence tomography[J]. Chinese Journal of Lasers, 2014, 41(7): 0704002(in Chinese).
[22] 乜彦华. OCT无创血糖检测穿戴式探头研究[D]. 保定: 河北大学, 2020: 19-40.NIE Y H. Research on wearable functional probe for non-invasive blood glucose detection in OCT[D]. Baoding: Hebei University, 2020: 19-40(in Chinese).
[23] YANG Y, WANG T H, BISWAL N C, et al. Optical scattering coefficient estimated by optical coherence tomography correlates with collagen content in ovarian tissue[J]. Journal of Biomedical Optics, 2011, 16(9): 090504. doi: 10.1117/1.3625247
[24] 李春春. 主成分分析(PCA)原理详解[EB/OL]. (2015-03-04)[2023-02-27]. https://blog.csdn.net/zhongkelee/article/details/44064401.LI Ch Ch. Principal component analysis (PCA) principle explanation[EB/OL]. (2015-03-04)[2023-02-27]. https://blog.csdn.net/zhongkelee/article/details/44064401(in Chinese).
[25] GIRI D, KOTHAI E, CHOWHAN D A, et al. Glucose tolerance test (GTT) : Principle, procedure, indications and interpretation[EB/OL]. (2022-03-07)[2022-11-18]. https://laboratoryinfo.com/glucose-tolerance-test-gtt-principle-procedure-indications-interpretation/.
[26] 姜晓彤. OGTT结果全是数字怎么解: 8个结果来说明[EB/OL]. (2015-10-08)[2023-02-01]. http://endo.dxy.cn/article/142057.JIANG X T. How to solve OGTT results that are all numbers: 8 results to illustrate[EB/OL]. (2015-10-08)[2023-02-01]. http://endo.dxy.cn/article/142057(in Chinese).
[27] YOSHIDA A, KIMURA T, TSUNEKAWA K, et al. Age-related sex differences in glucose tolerance by 75 g oral glucose tolerance test in Japanese[J]. Nutrients, 2022, 14(22): 4868. doi: 10.3390/nu14224868
[28] JAGANNATHAN R, NEVES J S, DORCELY B, et al. The oral glucose tolerance test: 100 years later[J]. Diabetes, Metabolic Syndrome and Obesity, 2020, 13: 3787-3805.
[29] CHUNG S T, HA J, ONUZURUIKE A U, et al. Time to glucose peak during an oral glucose tolerance test identifies prediabetes risk[J]. Clinical Endocrinology, 2017, 87(5): 484-491.
[30] KIM S H, PARK T S, JIN H Y. Rethinking the accuracy of 75 g glucose used in the oral glucose tolerance test in the diagnosis and management of diabetes[J]. Primary Care Diabetes, 2017, 11(6): 555-560.
[31] 苏亚, 孟卓, 于海民, 等. OCT无创检测技术的人体血糖平衡延迟时间研究[J]. 激光技术, 2015, 39(1): 19-22. doi: 10.7510/jgjs.issn.1001-3806.2015.01.004SU Y, MENG Zh, YU H M, et al. Study on blood glucose lag time in noninvasive measurement using optical coherence tomography[J]. Laser Technology, 2015, 39(1): 19-22(in Chinese). doi: 10.7510/jgjs.issn.1001-3806.2015.01.004